Loading...

Home
ETF
ALGS

ALGS

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ALGS News

Onco3R Appoints Lawrence Blatt as Board Chair to Drive Growth

Jan 08 2026Globenewswire

Aligos Grants 14,100 Stock Options to New Employees Under Inducement Plan

Dec 12 2025Globenewswire

Aligos Grants 14,100 Stock Options to New Employees as Inducement

Dec 12 2025Newsfilter

Aligos Therapeutics Presents Positive HBV and Weight Loss Data at HEP-DART 2025

Dec 11 2025Newsfilter

Aligos Therapeutics Reveals Inducement Grants in Accordance with Nasdaq Listing Rule 5635(c)(4)

Oct 17 2025Newsfilter

Biotech Stocks Surge After Hours Due to Trial Advancements, Funding Developments, and Anticipated Milestones

Sep 17 2025NASDAQ.COM

HC Wainwright & Co. Affirms Buy Rating for Aligos Therapeutics, Keeps $50 Price Target Intact

Sep 12 2025Benzinga

Can Aligos Therapeutics (ALGS) Surge by 737.74% According to Wall Street Analysts?

Sep 08 2025NASDAQ.COM

Sanofi Receives FDA Approval for Wayrilz in Treating Immune Thrombocytopenia

Sep 01 2025NASDAQ.COM

Aligos Therapeutics Enhances Executive Team by Appointing Ramón Polo as Senior Vice President and Head of Global Regulatory Affairs

Aug 20 2025Newsfilter

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 11 2025Newsfilter

Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)

Jun 18 2025Newsfilter

Aligos Therapeutics Issues 26,000-Share Inducement Grant To New Employee

May 16 2025NASDAQ.COM

Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

Apr 23 2025Newsfilter

Aligos Therapeutics Presents Positive Data at APASL 2025

Mar 26 2025Newsfilter

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 14 2025Newsfilter